Evidence map›Paper›PMID 38428749›Full record

ReviewAntiviral research2024

Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19-21, 2023.

Stephen R Welch, Aura R Garrison, Dennis A Bente, Felicity Burt, Jake D'Addiego, Stephanie Devignot, Stuart Dowall, Kerstin Fischer, David W Hawman, Roger Hewson and 5 more

Open access · greenAbstract readReview
In one paragraph

Review in Antiviral research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. One health investigation following a cluster of Crimean-Congo haemorrhagic fever, North Macedonia, July to November 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 7 countries.

Stephen R WelchViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: yos6@cdc.gov.
Aura R GarrisonVirology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.
Dennis A BenteGalveston National Laboratory, Department of Microbiology and Immunology, Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Felicity BurtDivision of Virology, National Health Laboratory Service and Division of Virology, University of the Free State, Bloemfontein, South Africa.
Jake D'AddiegoUK Health Security Agency, Porton Down, Salisbury, Wiltshire, UK.
Stephanie DevignotDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
Stuart DowallUK Health Security Agency, Porton Down, Salisbury, Wiltshire, UK.
Kerstin FischerInstitute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute of Animal Health, Greifswald-Insel Riems, Germany.
David W HawmanLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.
Roger HewsonUK Health Security Agency, Porton Down, Salisbury, Wiltshire, UK.
Ali MirazimiDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
Lisa OestereichBernhard Nocht Institute for Tropical Medicine and German Center for Infectious Research, Partner Sites Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany.
Zati VatanseverKafkas University, Faculty of Veterinary Medicine, Dept. of Parasitology, Kars, Turkey.
Jessica R SpenglerViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Anna PapaDepartment of Microbiology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
UK Health Security Agency · GBCenters for Disease Control and Prevention · USKarolinska University Hospital · SEAristotle University of Thessaloniki · GRBernhard Nocht Institute for Tropical Medicine · DEFriedrich-Loeffler-Institut · DEKafkas University · TRNational Health Laboratory Service · ZANational Institutes of Health · USThe University of Texas Medical Branch at Galveston · USUnited States Army Medical Research Institute of Infectious Diseases · US

Funding

Viral Hemorrhagic Fevers: Disease Modeling and TransmissionZIAAI001089 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2009 to 2025
$50.7M
Uganda International Center for Excellence in ResearchZIAAI001188 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2014 to 2025
$2.4M
Intramural CDC HHS CC999999
6 · The paper itself

Abstract

The Third International Conference on Crimean-Congo Hemorrhagic Fever (CCHF) was held in Thessaloniki, Greece, September 19-21, 2023, bringing together a diverse group of international partners, including public health professionals, clinicians, ecologists, epidemiologists, immunologists, and virologists. The conference was attended by 118 participants representing 24 countries and the World Health Organization (WHO). Meeting sessions covered the epidemiology of CCHF in humans; Crimean-Congo hemorrhagic fever virus (CCHFV) in ticks; wild and domestic animal hosts; molecular virology; pathogenesis and animal models; immune response related to therapeutics; and CCHF prevention in humans. The concluding session focused on recent WHO recommendations regarding disease prevention, control strategies, and innovations against CCHFV outbreaks. This meeting report summarizes lectures by the invited speakers and highlights advances in the field.

Indexed as

Hemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoTicksAnimalsDisease OutbreaksGreeceHumans

Identifiers

PMID38428749
PMCPMC11931574
OpenAlexW4392301104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.